ALK-Abello A/S ADR (AKABY)

86.2
0.0(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    86.2 - 86.2

AKABY Overview

Prev. Close
85.2
Day's Range
86.2-86.2
Revenue
-
Open
86.2
52 wk Range
31-104.4
EPS
-
Volume
0
Market Cap
3.98B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,308
P/E Ratio
-
Beta
-
1-Year Change
-9.26%
Shares Outstanding
220,209,840
Next Earnings Date
-
What is your sentiment on ALK-Abello ADR?
or
Vote to see community's results!

ALK-Abello A/S ADR Company Profile

ALK-Abello A/S ADR Company Profile

Employees
2480

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary